Monogram Expects to Report 2008 Revenues of $62M | GenomeWeb

NEW YORK (GenomeWeb News) – Monogram Biosciences said last week that it expects to report fiscal 2008 revenues of approximately $62 million, an increase of 44 percent over 2007 revenues of $43.2 million.

The South San Francisco, Calif.-based firm said that among the contributors to its revenue increase for the year were sales of $16 million from its Trofile assay, which is used to select HIV patients for CCR5 agonists, such as Pfizer's maraviroc (Selzentry).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.